T. Rowe Price Associates’s Amrize Ltd AMRZ Stock Holding History

T. Rowe Price Associates’s Portfolio AMRZ Stock Details AMRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.9M	Buy	260,093 +47,835	+23%	+$2.59M	﹤0.01%	1248
2026 Q1	$11.9M	Buy	212,258 +20,000	+10%	+$1.15M	﹤0.01%	1175
2025 Q4	$10.4M	Buy	192,258 +3,500	+2%	+$179K	﹤0.01%	1225
2025 Q3	$9.16M	Buy	+188,758	New	+$9.63M	﹤0.01%	1247

Other funds holding AMRZ

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Zurich Cantonal Bank Zurich, Switzerland $52.2B AUM 40.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates's AMRZ Position: Q2 2026 in Review

T. Rowe Price Associates increased its Amrize Ltd (AMRZ) stake by 23% in Q2 2026, buying an estimated $2.59M and bringing the position to 260,093 shares worth $13.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1248.

T. Rowe Price Associates first reported a position in AMRZ in Q3 2025 and has held it in 4 quarters since. 464 funds tracked by Wall St. Rank hold AMRZ as of Q2 2026.

T. Rowe Price Associates held 260,093 shares of Amrize Ltd worth $13.9M as of Q2 2026.
T. Rowe Price Associates bought 47,835 Amrize Ltd shares in Q2 2026, an estimated $2.59M.
Amrize Ltd made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1248 holding.
T. Rowe Price Associates first reported a position in Amrize Ltd in Q3 2025 and has held it in 4 quarters since.
464 funds tracked by Wall St. Rank held Amrize Ltd as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.